Gilead Sciences, Inc.
Processes and intermediates for preparing MCL1 inhibitors

Last updated:

Abstract:

The present disclosure provides methods for preparing MCL1 inhibitors or a salt thereof and related key intermediates.

Status:
Grant
Type:

Utility

Filling date:

20 Nov 2020

Issue date:

10 May 2022